Monday - January 19, 2026

Category Archives: Pharmaceuticals & Biotech

HER2-Negative Metastatic Breast Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai

The Key HER2-Negative Metastatic Breast Cancer Companies in the market include – Genentech, Inc., AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai Inc., Novartis Pharmaceuticals, Adagene Inc, Jiangsu HengRui Medicine Co., Ltd, Pfizer, Novartis, CytomX Therapeutics, Tyme, Inc, … Continue reading →

Knee Osteoarthritis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observe | Sanofi, Anterogen, Enlivex Therapeutics, ICM, Peptinov, Techfields Pharma, Paradigm Biopharma

The Key Knee Osteoarthritis Companies in the market include – Sanofi, Anterogen, Enlivex Therapeutics, ICM, Sao Thai Duong Joint Stock Company, Peptinov, Techfields Pharma, Taiwan Liposome Company, Centrexion Therapeutics, Biosplice Therapeutic, Noven Pharmaceuticals, Kolon TissueGene, Paradigm Biopharmaceuticals, Organogenesis, BioSenic (Bone … Continue reading →

Graves Ophthalmopathy Market Growth to Surge During Forecast Period (2024–2034), Says DelveInsight | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited

The Key Graves Ophthalmopathy Companies in the market include – Immunovant Sciences GmbH, Horizon Pharma USA, Inc., Viridian Therapeutics, Inc., Tourmaline Bio, Inc., ACELYRIN Inc., Hoffmann-La Roche, Horizon Therapeutics USA, Inc., Lassen Therapeutics Inc., Novartis, Sling Therapeutics, Inc., Lassen Therapeutics, … Continue reading →

Neurotrophic Keratitis Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotech

The Key Neurotrophic Keratitis Companies in the market include – Dompé Farmaceutici, BRIM Biotechnology, ReGenTree, LLC, Oyster Point Pharma, Inc., Syneos Health, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, and others.   DelveInsight’s “Neurotrophic Keratitis Market Insights, Epidemiology, and Market Forecast-2034″ … Continue reading →

Metastatic Prostate Cancer Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Merck, Arvinas Androgen Receptor, UNICANCER, Aragon Pharma, Mark Stein, Novartis

The Key Metastatic Prostate Cancer Companies in the market include – Curium US LLC, Bayer, Hookipa Biotech GmbH, University Health Network, Merck Sharp & Dohme, Arvinas Androgen Receptor, UNICANCER, Aragon Pharmaceuticals, Mark Stein, Novartis, Orion Corporation, Janssen Research & Development, … Continue reading →

Prostate Cancer Pipeline and Competitive Landscape: 150+ Companies, 160+ Therapies, and the Next Wave of FDA-Backed Innovation, analyses DelveInsight

Prostate Cancer Pipeline Leading organizations including Curium, Merck, Telix Pharmaceuticals, Exelixis, AstraZeneca, AB Science, Lantheus, Pfizer, Jiangsu Hengrui Pharmaceuticals, Modra Pharmaceuticals, Bristol-Myers Squibb, Zenith Epigenetics, Xencor, Merus, Phosplatin Therapeutics, Laekna Therapeutics, Tavanta Therapeutics, Madison Vaccines, Taiho Pharmaceutical, Ipsen Biopharmaceuticals, LAVA … Continue reading →

Neuroblastoma Market Size and Forecast (2025–2034): 7 Major Markets, 700-800 US Annual Cases, and 25+ Pipeline Assets | DelveInsight

Neuroblastoma Market Major players active in the neuroblastoma treatment space include United Therapeutics, EUSA Pharma, Y-mAbs Therapeutics, Clarity Pharmaceuticals, along with several other companies. The Neuroblastoma Treatment Market is expected to witness substantial growth through 2034. Nearly 90% of neuroblastoma … Continue reading →